AIDS Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of AIDS Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
AIDS Therapies (Protease Inhibitors)
European CPMP Adopts Positive Opinion for Reformulated Norvir Capsules
August 23rd, 1999
Abbott Laboratories, Abbott Park, Illinois, announced that the European Union's Committee for Proprietary Medicinal Products (CPMP) has adopted a positive opinion on Norvir (ritonavir) soft capsules. Norvir is a protease inhibitor indicated in combination with other anti-retroviral medications for the treatment of HIV infection. The CPMP opinion is considered by the European Commission, which makes a final decision regarding the issue of the marketing authorization, a process that takes approximately 90 days. The positive opinion on Norvir soft capsules follows intense reformulation work at Abbott after an announcement in July...
Source: AIDS Weekly (1999-08-23)
|
